Management of Anticoagulants and Antithrombotics in Patients With CSDH

Last updated: November 2, 2022
Sponsor: University Hospital of Ferrara
Overall Status: Active - Recruiting

Phase

N/A

Condition

Heart Defect

Coronary Artery Disease

Myocardial Ischemia

Treatment

N/A

Clinical Study ID

NCT05079295
1102/2020/Oss/AOUFe
  • Ages 18-95
  • All Genders

Study Summary

Primary objective of the study will be to compare, up to 6 months after surgery, number of relapses (post operative re-bleeding) or intracerebral hemorrhage (others than subdural hematomas) and thromboembolic or cardiovascular ischemic events, in patients undergoing surgery for chronic subdural hematoma (CSDH). These data will be correlated to the suspension or not of antithrombotics or anticoagulants before surgery or their re-introduction after surgery.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age > 18 years old
  • Informed consent
  • Evidence of CSDH which needs surgery
  • patients taking antithrombotics or anticoagulants

Exclusion

Exclusion Criteria:

  • previous surgery for CSDH

Study Design

Total Participants: 400
Study Start date:
February 20, 2021
Estimated Completion Date:
February 20, 2024

Connect with a study center

  • University Hospital Sant'Anna

    Ferrara, Emilia-Romagna 44124
    Italy

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.